Clinical trial
A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood…
NCT00422461 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00422461 |
|---|---|
| Title | A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure |
| Official title | A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF PF-00489791 IN SUBJECTS WITH STAGE 1 AND 2 ESSENTIAL HYPERTENSION USING AMBULATORY BLOOD PRESSURE MONITORING (ABPM) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | placebo, PF-00489791 |
| Enrollment | 135 |
| Start date | Feb 27, 2007 |
| Primary completion | Jan 28, 2008 |
| Completion | Jan 28, 2008 |
| First posted | Jan 17, 2007 |
| Last update posted | Oct 11, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: